Anaroxyl is a haemostatic medication containing 5 mg of adrenochrome monosemicarbazone per milliliter, manufactured by Nuvista Pharma Ltd. in Bangladesh. It is used to prevent and treat capillary bleeding, including conditions such as haemoptysis, haematuria, retinal hemorrhage, secondary hemorrhage, and menorrhagia. The injection is administered subcutaneously (SC), intramuscularly (IM), or intravenously (IV), depending on the clinical situation.